The notion that lipid metabolism dysregulation alters CD1-mediated immune responses and thereby promotes psoriasis is further supported by the finding that dyslipidemia is a risk factor for psoriasis patients156 and hyperlipidemic Tg mice that produce a CD1b-autoreactive T cell clone spontaneously developed psoriasiform dermatitis157. Here, CD1B is linked to metabolic syndrome.